Related Experiment Video
Updated: May 21, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Informing Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare
Marliese Alexander1,2, Chiao Xin Lim3,4, Senthil Lingaratnam1,2
1Pharmacy Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
This study developed survey tools to assess pharmacogenomics (PGx) knowledge and needs in cancer care professionals and patients. The goal is to inform strategies for integrating PGx into routine cancer treatment.
Area of Science:
- Pharmacogenomics
- Cancer Care
- Implementation Science
Background:
- Clinical pharmacogenomics (PGx) integration in cancer care is limited.
- Despite evidence and guidelines, routine use of PGx is suboptimal.
- There's a need to understand knowledge and attitudes of stakeholders.
Purpose of the Study:
- Develop survey tools for healthcare professionals (HCPs) and consumers (patients/carers).
- Assess knowledge, attitudes, practices, perceptions, and education needs regarding PGx.
- Inform strategies for implementing PGx in solid and hematologic cancers.
Main Methods:
- A three-phase mixed-methods approach was used for survey development.
- Systematic literature review and the Theoretical Domains Framework informed content.
- Priority partnership meetings and validity/health literacy assessments refined the tools.
Main Results:
- Separate survey tools were created for HCPs and consumers.
- Surveys cover demographics, experience, knowledge, attitudes, practices, perceptions, education, and vignettes.
- High content/face validity and acceptable health literacy (median Flesch Kincaid Grade 6) were achieved for consumer surveys.
Conclusions:
- Validated survey tools are ready for use in cancer care settings.
- Evidence generated will guide local PGx implementation strategies.
- The tools aim to promote broader integration of pharmacogenomics in clinical practice.
More Related Videos
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...